Spruce Biosciences, Inc. SPRB 深 沪
等待开盘 09-23 09:30:00 美东时间
9.08
+0.705
+8.42%
华盛通- 最 高9.64
- 今 开8.7499
- 成交量 1.64万股
- 最 低 8.20
- 昨 收 8.375
- 总市值 3.83亿
- 52周最高 11.64
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 8.05
- 委 比 51.52%
- 总股本 4223.13万
- 历史最高 11.64
- 量 比 0.59
- 振 幅 17.19%
- 历史最低 8.05
- 每 手 1
- 风险率 1.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Check-Cap (NASDAQ:CHEK) shares rose 225.1% to $2.42 during Monday's re...
09-16 01:06
Spruce Biosciences resumes Nasdaq trading; shares up over 40%
Spruce Biosciences (OTC:SPRB) will resume trading on Nasdaq, September 15, 2025. The company focuses on developing therapies for neurological disorders with high unmet medical need. SPRB shares up 40....
09-15 19:42
Spruce Biosciences To Resume Trading On Nasdaq Capital Market At Market Open On September 15, Under Ticker Symbol "SPRB"
Spruce Biosciences, Inc. (NASDAQ:SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced that it
09-15 19:05
Spruce Biosciences Reports Promising Clinical Advances
Spruce Biosciences, Inc. ( ($SPRBD) ) has released its Q2 earnings. Here is a b...
08-20 11:58
Spruce Biosciences GAAP EPS of -$3.50
Spruce Biosciences press release (OTC:SPRBD): Q2 GAAP EPS of -$3.50. Cash and cash equivalents as of June 30, 2025 were $16.4 million. Cash and cash equivalents are expected to allow the company to fu...
08-15 18:40
Spruce Biosciences Q2 EPS $(3.50) Beats $(19.13) Estimate
Spruce Biosciences (NASDAQ:SPRB) reported quarterly losses of $(3.50) per share which beat the analyst consensus estimate of $(19.13) by 81.7 percent. This is a 1490.91 percent decrease over losses of $(0.22) per share
08-15 04:28
凯雷Q2继续重仓航空维修巨头StandardAero(SARO.US) 清仓文远知行(WRD.US)
全球另类资产管理巨头凯雷(CARLYLE GROUP INC)递交了截止至2025年6月30日的第二季度持仓报告(13F)。
08-13 18:47
HC Wainwright & Co. Reiterates Neutral on Spruce Biosciencesto Neutral
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spruce Biosciences (NASDAQ:SPRB) from Neutral to Neutral.
04-28 19:52
Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Shares of Amplify Energy Corp. (NYSE:AMPY) rose sharply in today's pre-market a...
04-28 17:10
美股大行评级 | 潜在涨幅195.08%！Absci获Keybanc升目标价至9美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1119548656129204224.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Keybanc：维持Absci(ABSI)"超配"评级，目标价从5美元升至9美元</p> <p>• Keybanc：维持AbCellera Biologics(ABCL)"超配"评级，目标价从4美元升至5美元</p> <
04-17 08:46
